Shire Agrees to Acquisition by Takeda Pharmaceutical

Takeda Pharmaceutical Company and Shire announced on Tuesday May 8 that they have reached agreement for Takeda to acquire Shire for $805 billion...

Read More

Dry Eye Disease Treatment Xiidra Approved by FDA

Shire announces that the US Food and Drug Administration (FDA) has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop...

Read More